Welcome to our dedicated page for Adagio Medical SEC filings (Ticker: ADGM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Clinical trial data, FDA milestones, and complex R&D accounting make Adagio Medical Holdings’ disclosures tough to navigate. Each 300-page 10-K buries details on cryoablation catheter safety tests, while 8-K updates can signal pivotal regulatory decisions overnight. If you have ever asked, “Where can I find Adagio Medical Holdings’ quarterly earnings report 10-Q filing?” or “How do I track Adagio Medical Holdings insider trading Form 4 transactions?”, you know the challenge.
Stock Titan solves that problem. Our AI reads every new submission to EDGAR in seconds, extracts the sections that matter, and explains them in plain language. From real-time alerts on Adagio Medical Holdings Form 4 insider transactions to side-by-side comparisons of R&D spend across quarters, you get answers—not page counts. Want the key risk factors from the latest annual report? Our summaries turn the Adagio Medical Holdings annual report 10-K simplified into a two-minute brief. Curious about management pay? The platform highlights numbers inside the proxy statement executive compensation table and links them to performance metrics.
Every filing type is at your fingertips: 10-K, 10-Q, 8-K material events explained, S-1 pipeline updates, and, of course, Adagio Medical Holdings executive stock transactions Form 4 with real-time push alerts. Use the data to monitor insider sentiment before major trial readouts, compare device sales growth quarter-over-quarter, or understand cash runway without combing through footnotes. Stock Titan turns understanding Adagio Medical Holdings SEC documents with AI into a straightforward part of your workflow.
RA Capital and affiliated persons report beneficial ownership of Adagio Medical common stock equal to 1,200,000 shares, representing 7.2% of the outstanding class as of June 30, 2025. The filing clarifies that 1,140,000 of those shares are issuable upon exercise of warrants held directly by RA Capital Healthcare Fund, L.P., and 60,000 are issuable upon exercise of warrants held by RA Capital Nexus Fund II, L.P. RA Capital, Dr. Kolchinsky and Mr. Shah note delegated voting and dispositive powers for the funds and file this Amendment to correct a prior clerical omission of the warrant-based holdings.
RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky and Rajeev Shah filed an amendment to a Schedule 13G regarding Adagio Medical Holdings, Inc. The filing states that each Reporting Person beneficially owns 0 shares of Adagio common stock, representing 0.0% of the class as of June 30, 2025. The Reporting Persons expressly disclaim being a group and confirm the shares were not acquired to influence control of the issuer.
Adagio Medical Holdings furnished a press release announcing its financial results for the quarter ended June 30, 2025 and provided a business update; the release is attached as Exhibit 99.1.
The company also updated its corporate presentation for investor and analyst use, made available on its website and attached as Exhibit 99.2. Both items are expressly stated as furnished (not filed) under the Exchange Act.
Adage Capital Management, L.P., together with individuals Robert Atchinson and Phillip Gross, reported beneficial ownership of 821,261 shares of Adagio Medical Holdings, Inc. common stock, representing 5.34% of the class. The percentage was calculated using 15,381,565 shares outstanding as of May 7, 2025, per the company quarterly report filed May 15, 2025. The Schedule 13G shows shared voting and shared dispositive power over all 821,261 shares and includes a certification that the securities were acquired and are held in the ordinary course of business and not to influence control. The filing lists the issuer office in Laguna Hills, CA, and includes a joint filing agreement as Exhibit 99.1.
FAQ
What is the current stock price of Adagio Medical (ADGM)?
What is the market cap of Adagio Medical (ADGM)?
